Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Kairos Pharma (KAPA) Return on Sales (2024 - 2025)

Kairos Pharma's Return on Sales history spans 2 years, with the latest figure at 0.03% for Q4 2025.

  • For Q4 2025, Return on Sales changed 0.0% year-over-year to 0.03%; the TTM value through Dec 2025 reached 0.03%, up 3.0%, while the annual FY2025 figure was 0.11%, 9.0% down from the prior year.
  • Return on Sales reached 0.03% in Q4 2025 per KAPA's latest filing, up from 0.03% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 19.5% in Q2 2024 to a low of 0.03% in Q4 2024.